Cronos Group, Inc. Loss Form
Company: Cronos Group, Inc.
Ticker: (NASDAQGM) CRON
Deadline
Passed
Lead Plaintiff Deadline: November 05, 2018
Every year, thousands of shareholders miss deadlines to receive settlement funds. Make sure you don’t. Sign up for case alerts.
To receive more detailed alerts provide your information below.
Request Case Alerts
Allegations
(1) the size of Cronos’ distribution agreements with the Canadian provinces was relatively small; and (2) as a result of the foregoing, Defendants’ positive statements about Cronos’ business, operations, and prospects were materially false and/or misleading, and/or lacked a reasonable basis.
On August 30, 2018, Citron Research published an article entitled “Cronos: The Dark Side of Cannabis Space,” alleging, among other things, that the Company has been “deceiving the investing public by purposely not disclosing the size of its distribution agreements with provinces – unlike every other major cannabis player” and that this was because “the agreements are so small that they could never justify the premium investors are paying for the stock.” On this news, Cronos’ share price fell over 28%, to close at $9.12 per share on August 30, 2018.